Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?

International Journal of Oncology
Antonio ChiappaRoberto Biffi

Abstract

The present study determines the oncologic outcome of the combined resection and ablation strategy for colorectal liver metastases (CRLM). Between January 1994 and December 2014, 360 patients underwent surgery for CRLM. There were 280 patients who underwent hepatic resection only (group 1) and 80 hepatic resection plus ablation (group 2). group 2 patients had a higher incidence of multiple metastases than group 1 cases (100% in group 2 vs. 28.2% in group 1; P<0.001) and bilobar involvement (76.5% in group 2 vs. 12.9% in group 1; P<0.001). Perioperative mortality was nil in either group with a higher postoperative complication rate amongst group 1 vs. group 2 cases (18 vs. 0, respectively). The median follow-up was 90 months (range, 1-180) with a 5-year overall survival for group 1 and group 2 of 49 and 80%, respectively (P=0.193). The median disease-free survival for patients with R0 resection was 50, 43 and 34% at 1, 2 and 3 years, respectively, and remained steadily higher (at 50%) in those patients treated with resection combined with ablation up to 5 years (P=0.069). The only intraoperative ablation failure was for a large lesion (≥5 cm). Our data support the use of intraoperative ablation when complete hepatic resection ca...Continue Reading

References

Feb 12, 1998·Annals of Internal Medicine·D B Rubin
Feb 12, 2000·American Journal of Surgery·A S PearsonS A Curley
Nov 23, 2000·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D EliasT de Baere
May 3, 2002·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·J MachiR H Oishi
May 30, 2002·Annals of Surgery·Robert C G MartinDavid P Jaques
Sep 26, 2002·The British Journal of Surgery·S MulierL Michel
Nov 5, 2003·Annals of Surgical Oncology·Timothy M PawlikSteven A Curley
Oct 13, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Benoist, B Nordlinger
Feb 19, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Boyle, J Ferlay
Jun 24, 2005·International Journal of Colorectal Disease·Joachim K SeifertTheodor Junginger
Feb 18, 2006·ANZ Journal of Surgery·Mehrdad NikfarjamChristopher Christophi
Jul 22, 2006·Annals of Surgery·Sylvain ManfrediAnne-Marie Bouvier
Jul 4, 2007·Surgical Oncology Clinics of North America·René AdamThomas Aloia
Feb 3, 2009·World Journal of Surgery·Robert M EiseleGuido Schumacher
Mar 31, 2012·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Kwan Ho LeeWon Kon Han
Jun 15, 2012·The Cochrane Database of Systematic Reviews·Roberto CirocchiIosief Abraha
Mar 16, 2013·World Journal of Surgery·Karin NielsenM Petrousjka van den Tol
Mar 4, 2014·Journal of Visceral Surgery·A StoltzM Rivoire
May 31, 2014·World Journal of Gastroenterology : WJG·Özgür AkgülMesut Tez
May 31, 2014·BioMed Research International·Smit SinglaBoris Kuvshinoff

❮ Previous
Next ❯

Citations

May 28, 2019·The British Journal of Radiology·Moritz T WinkelmannRüdiger Hoffmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.